International Journal of Technology Assessment in Health Care

Papers
(The TQCC of International Journal of Technology Assessment in Health Care is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-02-01 to 2024-02-01.)
ArticleCitations
The new definition of health technology assessment: A milestone in international collaboration200
Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations70
Health technology assessment frameworks for eHealth: A systematic review41
Home-based telerehabilitation software systems for remote supervising: a systematic review33
Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders32
Real-world data for health technology assessment for reimbursement decisions in Asia: current landscape and a way forward30
Principles for deliberative processes in health technology assessment29
Using QALYs versus DALYs to measure cost-effectiveness: How much does it matter?26
Real-world evidence use in assessments of cancer drugs by NICE22
The broader societal impacts of COVID-19 and the growing importance of capturing these in health economic analyses21
The effects of mobile apps on stress, anxiety, and depression: overview of systematic reviews21
Patient and public involvement in health technology assessment: update of a systematic review of international experiences20
Defining the role of the public in Health Technology Assessment (HTA) and HTA-informed decision-making processes19
Cost-effectiveness evaluation for pricing medicines and devices: A new value-based price adjustment system in Japan18
Health technology assessment for digital technologies that manage chronic disease: a systematic review16
Development of a checklist to guide equity considerations in health technology assessment16
The link between health technology assessment and decision making for the allocation of health resources in Latin America14
Exploring the identification, validation, and categorization of costs and benefits of education in mental health: The PECUNIA project13
Canadian cost-effectiveness model of BRCA-driven surgical prevention of breast/ovarian cancers compared to treatment if cancer develops13
Development of a health technology assessment module for evaluating mobile medical applications13
Real-world evidence: perspectives on challenges, value, and alignment of regulatory and national health technology assessment data collection requirements12
Evaluation of 3D printing costs in surgery: a systematic review12
Do existing real-world data sources generate suitable evidence for the HTA of medical devices in Europe? Mapping and critical appraisal12
Early economic evaluation to guide the development of a spectroscopic liquid biopsy for the detection of brain cancer12
Expertise, experience, and excellence. Twenty years of patient involvement in health technology assessment at NICE: an evolving story11
Mind the evidence gap: the use of patient-based evidence to create “complete HTA” in the twenty-first century11
Economic evaluation guidelines in low- and middle-income countries: a systematic review11
Beyond the numbers: a critique of quantitative multi-criteria decision analysis11
Considering and communicating uncertainty in health technology assessment11
On the integration of early health technology assessment in the innovation process: reflections from five stakeholders11
Investigating the attitude of patients with chronic diseases about using mobile health10
An institutional ethnographic analysis of public and patient engagement activities at a national health technology assessment agency10
A review of audiovisual telemedicine utilization and satisfaction assessment during the COVID-19 pandemic10
Exploring the identification, validation, and categorization of the cost and benefits of criminal justice in mental health: the PECUNIA project10
COVIDIAGNOSTIX: health technology assessment of serological tests for SARS-CoV-2 infection9
Exploring the opportunities for alignment of regulatory postauthorization requirements and data required for performance-based managed entry agreements9
Systematic review search methods evaluated using the Preferred Reporting of Items for Systematic Reviews and Meta-Analyses and the Risk Of Bias In Systematic reviews tool9
Measuring patient satisfaction with video consultation: a systematic review of assessment tools and their measurement properties9
Developing a quality management system for the European Network for Health Technology Assessment (EUnetHTA): toward European HTA collaboration9
Evaluation of the impact of patient input in health technology assessments at NICE9
Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis8
Addressing the challenges of implementing a Health Technology Assessment Policy Framework in South Africa8
Integrating Empirical Analysis and Normative Inquiry in Health Technology Assessment: The Values in Doing Assessments of Health Technologies Approach7
Estimating the fiscal impact of three vaccination strategies in Italy7
Environmental impact assessment in health technology assessment: principles, approaches, and challenges7
The estimation of health state utility values in rare diseases: overview of existing techniques7
Examining the impact of different country processes for appraising rare disease treatments: a case study analysis7
Patient involvement in relative effectiveness assessments in the European Network for Health Technology Assessment7
NICE's evaluations of medicines authorized by EMA with conditional marketing authorization or under exceptional circumstances7
Value of mesenchymal stem cell therapy for patients with septic shock: an early health economic evaluation7
The NICE MEDLINE and Embase (Ovid) health apps search filters: development of validated filters to retrieve evidence about health apps7
How to integrate evidence from patient preference studies into health technology assessment: a critical review and recommendations7
Developing recommendations for the diagnosis and treatment of Lyme disease: the role of the patient's perspective in a controversial environment7
Analysis of PBAC submissions and outcomes for medicines (2010–2018)6
Application of a health technology assessment framework to digital health technologies that manage chronic disease: a systematic review6
Cost-effectiveness of treating head and neck cancer using intensity-modulated radiation therapy: implications for cancer control program in India6
Determinants of Managed Entry Agreements in the context of Health Technology Assessment: a comparative analysis of oncology therapies in four countries6
The learning curve in transcatheter aortic valve implantation clinical studies: A systematic review6
Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force6
A review of HTA guidelines on societal and novel value elements6
Peer review of searches for studies for health technology assessments, systematic reviews, and other evidence syntheses6
Can multi-criteria decision analysis (MCDA) be implemented into real-world drug decision-making processes? A Canadian provincial experience6
A different animal? Identifying the features of health technology assessment for developers of medical technologies6
Exploration of the visibility of patient input in final recommendation documentation for three health technology assessment bodies5
Relevance of the newly defined Health Technology Assessment: COVID-19 and beyond5
Health technology assessment applied to emergency preparedness: a new perspective5
Model for ASsessing the value of Artificial Intelligence in medical imaging (MAS-AI)5
On the role of cost-effectiveness thresholds in healthcare priority setting5
A toolkit of methods of development-focused health technology assessment5
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework5
Patient and public involvement in Health Technology Assessment: a new dawn?5
Prioritizing critical-care resources in response to COVID-19: lessons from the development of Thailand's Triage protocol5
Evaluation of patient involvement strategies in health technology assessment in Spain: the viewpoint of HTA researchers5
Toward a common understanding of competencies for health technology assessment: enhancing educational and training programs around the globe5
A framework for action to improve patient and public involvement in health technology assessment5
Implementation of a new Digi-HTA process for digital health technologies in Finland5
Assessing the capacity of Ghana to introduce health technology assessment: a systematic review of economic evaluations conducted in Ghana5
Collaboration applications for mixed home care — A systematic review of evaluations and outcomes4
Postlaunch evidence-generation studies for medical devices in Spain: the RedETS approach to integrate real-world evidence into decision making4
Physician–patient shared decision making, patient satisfaction, and adoption of new health technology in China4
A model-based study to estimate the health and economic impact of health technology assessment in Thailand4
Tisagenlecleucel for relapsed/refractory acute lymphoblastic leukemia in the Irish healthcare setting: cost-effectiveness and value of information analysis4
Considerations for transferability of health technology assessments: a scoping review of tools, methods, and practices4
Efficiency of telemedicine for acute stroke: a cost-effectiveness analysis from a French pilot study4
Quality of health economic evaluations submitted to the Italian Medicines Agency: current state and future actions4
Technology assessment framework for precision health applications4
Cost-effectiveness analysis of magnetic resonance-guided focused ultrasound ablation for palliation of refractory painful bone metastases4
Application of evidence-informed deliberative processes in health technology assessment in low- and middle-income countries4
Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?4
Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health4
Health Technology Assessment in Support of National Health Insurance in South Africa4
How does HTA addresses current social expectations? An international survey3
Integrating Early Economic Evaluation into Target Product Profile development for medical tests: advantages and potential applications3
Health technology assessment 2025 and beyond: lifecycle approaches to promote engagement and efficiency in health technology assessment3
Development of a decisional flowchart for meaningful patient involvement in Health Technology Assessment3
Integration of ethical considerations into HTA reports: an analysis of integration levels using a systematic review3
Integrating organizational impacts into health technology assessment (HTA): an analysis of the content and use of existing evaluation frameworks3
Establishment and implementation of hospital-based health technology assessment at King Hussein Cancer Center: can our model be an example?3
Effectiveness, efficacy, and safety of wearable cardioverter-defibrillators in the treatment of sudden cardiac arrest – Results from a health technology assessment3
Desirability and acceptability of a treatment-sequencing model in relapsing-remitting multiple sclerosis: A health technology assessment perspective3
Addressing uncertainty in relative effectiveness assessments by HTA organizations3
Values, principles, strategies, and frameworks underlying patient and public involvement in health technology assessment and guideline development: a scoping review3
Systems thinking in health technology assessment: a scoping review3
Lessons from the vaginal mesh scandal: enhancing the patient-centric approach to informed consent for medical device implantation3
Health technology assessment: A matter of facts and values3
Overview of information retrieval in a hospital-based health technology assessment center in a Swedish region3
Evaluating traditional and complementary medicines: Where do we go from here?3
Strengthening patient outcome evidence in health technology assessment: a coproduction approach3
Qualitative comparative analysis of health economic evaluation guidelines for health technology assessment in European countries3
Pilot approach to analyzing patient and citizen involvement in health technology assessment in four diverse low- and middle-income countries3
Economic evaluation and costs of remote patient monitoring for cardiovascular disease in the United States: a systematic review3
Using discrete-choice experiments to elicit preferences for digital wearable health technology for self-management of chronic kidney disease3
PP424 Piloting A Comprehensive Search For eHealth Definitions In The Grey Literature: Preliminary Results From A Systematic Scoping Review3
Evaluating physicians’ perspectives on the efficiency and effectiveness of the electronic prescribing system3
Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group3
Developing an agency's position with respect to patient involvement in health technology assessment: the importance of the organizational culture3
Evidence-based searching for health technology assessment: keeping up to date with SuRe Info3
Redefining Health Technology Assessment: A Comment on “The New Definition of Health Technology Assessment: A Milestone in International Collaboration”3
The representation of public values in health technology assessment to inform funding decisions: the case of Australia's national funding bodies3
Quality of economic evaluations of drug-coated balloons and drug-eluting stents in peripheral artery disease: a systematic review3
Stakeholder preferences for attributes of digital health technologies to consider in health service funding3
Creating enriched training sets of eligible studies for large systematic reviews: the utility of PubMed's Best Match algorithm3
Exploring facilitators and barriers to introducing health technology assessment: a systematic review2
Health technology assessment of diagnostic tests: a state of the art review of methods guidance from international organizations2
Benchmarking health technology assessment agencies—methodological challenges and recommendations2
Glycated hemoglobin as a surrogate for evaluating the effectiveness of drugs in diabetes mellitus trials: a systematic review and trial-level meta-analysis2
Learning and practicing more value-reflective, problem-setting health technology assessment: experiences and lessons from the VALIDATE project2
PP40 Health Apps To Manage Depression: Can We Separate The Grain From The Chaff? EvalDepApps Project2
Adherence to country-specific guidelines among economic evaluations undertaken in three high-income and middle-income countries: a systematic review2
Valuing Alzheimer's disease drugs: a health technology assessment perspective on outcomes2
Economic evaluation of genomic/genetic tests: a review and future directions2
Facilitating More Efficient Negotiations for Innovative Therapies: A Value-Based Negotiation Framework – Corrigendum2
Demonstrating the influence of HTA: INAHTA member stories of HTA impact2
Understanding innovation of health technology assessment methods: the IHTAM framework2
Development of an international template to support patient submissions in Health Technology Assessments2
PP162 Digital Medication Health Service Platforms Of Pharmaceutical Companies As Novel Sources Of Real-World Data For Health Technology Assessment2
Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 32
Patient and caregiver engagement in the Patient-Centered Outcomes Research Institute (PCORI) Health Care Horizon Scanning System (HCHSS) process2
Disagreement on cancer drug decisions in Europe2
Sustainability of healthcare systems in Asia: exploring the roles of horizon scanning and reassessment in the health technology assessment landscape2
Feasibility study to characterize price and reimbursement decision-making criteria for the inclusion of new drugs in the Spanish National Health System: the cefiderocol example2
A framework for local-level economic evaluation to inform implementation decisions: health service interventions to prevent hospital-acquired hypoglycemia2
Health technology assessment of whole genome sequencing in the diagnosis of genetic disorders: a scoping review of the literature2
Physicians' perception toward non-invasive prenatal testing through the eye of the Rogers' diffusion of innovation theory in China2
The fourth edition of the European Network for Health Technology Assessment Forum: highlights and outcomes2
Postlaunch evidence generation practices among health technology assessment bodies in Europe2
Disruptive technologies in health care disenchanted: a systematic review of concepts and examples2
A different animal but the same beast? Using development-focused health technology assessment to define the value proposition of medical technologies2
Projecting effectiveness after ending a randomized controlled trial: a two-state Markov microsimulation model2
Should We Pay for Scientific Knowledge Spillovers? The Underappreciated Value of “Failed” R&D Efforts2
Assessing the value of healthcare innovations: a proposal for an integrated health technology assessment–responsible innovation in health approach in the “new normal”2
A systematic literature review of revealed preferences of decision-makers for recommendations of cancer drugs in health technology assessment2
A Review of Overall Survival Extrapolations of Immune-Checkpoint Inhibitors Used in Health Technology Assessments by the French Health Authorities2
Information specialist collaboration in Europe: collaborative methods, processes, and infrastructure through EUnetHTA2
Hospital-based health technology assessment in Brazil: current experiences and challenges2
Economic impact of the use of the National Surgical Quality Improvement Program2
Disinvestment in healthcare: a scoping review of systematic reviews2
Evaluation of the impact of patient involvement in health technology assessments: A scoping review2
A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases2
PD20 Real-World Evidence To Support Single Arm Trials Of Oncology Interventions: Necessity or ‘NICE’ (National Institute for Health and Care Excellence) to Have?2
Promoting health economic evaluation studies in the AYUSH system of medicine: the need of the hour2
Patient-centered health technology assessment: a perspective on engagement in health technology assessment by three patient organizations and a health technology assessment body2
The contribution of French patient and consumer groups to health technology assessments over a 2-year period: an observational retrospective study2
European collaboration on health technology assessment: looking backward and forward1
EUnetHTA relative effectiveness assessments: efforts to increase usability, transparency and inclusiveness1
Novel approach to decision making for orphan drugs1
PP553 Study On The Utilization Of Medical Resources In Patients With Malignant Tumors in China1
Lessons learned from the reimbursement policy for immune checkpoint inhibitors and real-world data collection in Taiwan1
Bridging health technology assessment and healthcare quality improvement using international consortium of health outcomes measurement standard sets1
Informing decision makers about public preferences for different modalities of cancer treatment in the Rhône–Alps region in France1
PP434 Quality Of Studies Submitted To Support Requests For Medical Devices And Equipment Incorporation In A Teaching Hospital1
The rationale and design of public involvement in health-funding decision making: focus groups with the Canadian public1
Community engagement in Health Technology Assessment and beyond: from guests in the process to hosts1
A Technical Review of the ISPOR Presentations Database Identified Issues in the Search Interface and Areas for Future Development1
Using social media research in health technology assessment: stakeholder perspectives and scoping review1
Assessing the early impact of a hospital-based health technology assessment program, smart innovation1
Value assessment of antimicrobials and the implications for development, access, and funding of effective treatments: Australian stakeholder perspective1
PP228 Strategy For Including Information On The Research Priorities Of Patients And Experts In Health Technology Assessment Reports1
A consensus-based checklist for the critical appraisal of cost-of-illness (COI) studies1
Neglected impacts of patient decision-making associated with genetic testing1
PP112 Review On Change Management Models In Multi-Lateral, Multi-Stakeholder Contexts To Engage Stakeholders1
Early Dialogues for Pharmaceutical Products in European Network for Health Technology Assessment Joint Action 3: What Was Done and Where to Go in the Future1
Increasing the impact of budget impact analysis: incorporating uncertainty for decision-makers in small markets1
Do France, Germany, and Italy agree on the added therapeutic value of medicines?1
Patient Perspectives: An Integral Part of Health Technology Assessment Methodology1
Assessment of technical errors and validation processes in economic models submitted by the company for NICE technology appraisals1
The development process of economic evaluation guidelines in low- and middle-income countries: a systematic review1
Mecanismos de identificación y priorización de las tecnologías sanitarias a ser evaluadas por las Agencias de ETESA para decisiones de cobertura en Latino America1
OP223 A Semi-Automated Process To Monitor The Clinical Development And Regulatory Approval Pathway Of Innovative Medicines1
Impact of rarity on Canadian oncology health technology assessment and funding1
A review of implementation frameworks to operationalize health technology assessment recommendations for medical technologies in the Singapore setting1
Test–retest reliability of the Cost for Patients Questionnaire1
The cost of metastatic prostate cancer using time-driven activity-based costing1
PD45 Paying For Digital Health: What Evidence Is Needed?1
Towards greater impact in health technology assessment: horizon scanning for new and emerging technologies in Singapore1
PP90 Effectiveness Of Music Therapy For Autism Spectrum Disorder, Dementia, Depression, Insomnia, And Schizophrenia1
Adjustment of publication bias using a cumulative meta-analytic framework1
OP248 A Minimum Data-Set For Left Ventricular Assist Device On Destination Therapy: Cross-Border Collaboration Pilot On Real World Data1
Manufacturers’ perceptions of the decision-making process for new drug reimbursement in South Korea1
Involvement of information specialists and statisticians in systematic reviews1
Expanding health technology assessment towards broader value: Ireland as a case study1
PP385 Using Common Data Models And Data Networks For Evidence Generation In Health Technology Assessment1
Early access schemes for innovative health technologies: the views of international stakeholders1
A voice to be heard: patient and public involvement in health technology assessment and clinical practice guidelines in Malaysia1
PP290 Ongoing Swedish Initiatives To Improve The Potential For Real World Data Assessment Of Medical Devices1
OP283 A Pipeline Analysis Of Advanced Therapy Medicinal Products (ATMPs) In Late-Stage Clinical Development1
PP265 Application Of A Case-Mix Method For Medical Consumables Management In Anhui Province, China Using Healthcare Big Data1
Beyond clinical and cost-effectiveness: The contribution of qualitative research to health technology assessment1
OP87 Value From A Multi-stakeholder Perspective: A Framework To Assess Digital Health Solutions For Improving Chronic Disease Management1
Using INTEGRATE-HTA for the assessment of videorasterstereography in idiopathic scoliosis1
Regulatory, health technology assessment and company interactions: the current landscape and future ecosystem for drug development, review and reimbursement1
Response to “UNCERTAINTY MANAGEMENT IN REGULATORY AND HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING ON DRUGS: GUIDANCE OF THE HTAi-DIA WORKING GROUP”1
A systematic review of economic evaluations for RPE65-mediated inherited retinal disease including HTA assessment of broader value1
OP520 Evaluating Long-Term Survival From Clinical Trials: Does Real-World Evidence Change the Paradigm?1
Survey investigating the knowledge and awareness of payers and patient advocacy groups about the health technology assessment process in Lebanon1
Mapping horizon scanning systems for medical devices: similarities, differences, and lessons learned1
European Network for Health Technology Assessment’s Response to COVID-19: Rapid Collaborative Reviews on Diagnostic Tests and Rolling and Rapid Collaborative Reviews on Therapeutics1
PP261 Development Of A Mapping Algorithm To Predict SF-6D Values In People With Drug-Resistant Focal Onset Seizures1
Review of real-world evidence studies in type 2 diabetes mellitus: Lack of good practices1
PP414 Improving The Accessibility Of Scottish Medicines Consortium Advice1
OP535 Cost-Effectiveness Of Internet-Based HIV Screening In Men Who Have Sex With Men in Vancouver, British Columbia, Canada1
OP218 Searching Preprint Repositories For COVID-19 Therapeutics Using A Semi-Automated Text-Mining Tool1
International experience with performance-based risk-sharing arrangements: implications for the Chinese innovative pharmaceutical market1
Fit for the future? Status of health-related quality of life research in South Africa1
Quality of economic evaluations of ventricular assist devices: A systematic review1
Core competencies for ethics experts in health technology assessment1
Key learnings from Institute for Clinical and Economic Review’s real-world evidence reassessment pilot1
Opportunities to improve reporting of rapid response in health technology assessment1
Decision making for early surgical technology adoption into Canada’s healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities1
Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach1
Eliciting uncertainty for complex parameters in model-based economic evaluations: quantifying a temporal change in the treatment effect1
Access to medicines in Turkey: Evaluation of the process of medicines brought from abroad1
PP531 Quality Of Life Of Patients With Long-Chain Fatty Acid Oxidation Disorders Before And During Treatment With Triheptanoin1
A HTA of what? Reframing through including patient perspectives in health technology assessment processes1
OP01 Convergent Validity Between Discrete Choice Experiment And Other Stated Preference Methods: A Multistudy Comparison1
Is the assumption of waning of treatment effect applied consistently across NICE technology appraisals? A case-study focusing on disease-modifying therapies for treatment of multiple sclerosis1
Emerging healthcare interventions: Patient-Centered Outcomes Research Institute’s programmatic initiative1
Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling1
Evaluation of precision medicine assessment reports of the Belgian healthcare payer to inform reimbursement decisions1
Best practice considerations on the assessment of robotic assisted surgical systems: results from an international consensus expert panel1
Topic selection process in health technology assessment agencies around the world: a systematic review1
Vínculo Entre La Evaluación De Tecnologías Sanitarias y La Toma De Decisión Para La Asignación De Recursos Sanitarios en Latino-América1
PD33 Development And Validation Of A Machine Learning-Based Prediction Model For COVID-19 Diagnosis Using Patients’ Metabolomic Profile Data1
Use of real-world data and evidence for medical devices: a qualitative study of key informant interviews1
Synthesizing quantitative and qualitative information on multiple comparisons of health interventions to facilitate knowledge transfer: an example from an EUnetHTA multi-HTA1
PP112 Review On Change Management Models In Multi-Lateral, Multi-Stakeholder Contexts To Engage Stakeholders – Erratum0
OP366 Characterizing The Population At Risk Of Chronic Obstructive Pulmonary Disease In China Using A Real-World Population Survey0
Nonsurgical periodontal treatment in type II diabetics in a middle-income country: a cost-effectiveness analysis0
A collaborative pilot on current awareness alerts for disinvestment and horizon scanning0
Methods and criteria for the assessment of orphan drugs: a scoping review0
0.033631086349487